Skip to main content
logo
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.730
-0.110 (-3.87%)
At close: Jan 7, 2026, 4:00 PM EST
2.650
-0.080 (-2.93%)
After-hours: Jan 7, 2026, 7:55 PM EST

Company Description

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
CountryUnited States
Founded1984
IndustryMedical Devices
SectorHealthcare
Employees9
CEOJames Frakes

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone619 941 0360
Websiteaethlonmedical.com

Stock Details

Ticker SymbolAEMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0000882291
CUSIP Number00808Y604
ISIN NumberUS00808Y6041
Employer ID13-3632859
SIC Code3841

Key Executives

NamePosition
James B. Frakes M.B.A.Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Director
Guy F. Cipriani BS (Eng.), MBASenior Vice President and Chief Operating Officer
Dr. Steven P. LaRosa M.D.Chief Medical Officer
Michele BombardiereVice President and Controller

Latest SEC Filings

DateTypeTitle
Jan 7, 2026S-1General form for registration of securities under the Securities Act of 1933
Jan 2, 2026EFFECTNotice of Effectiveness
Dec 23, 2025S-3Registration statement under Securities Act of 1933
Dec 23, 2025DNotice of Exempt Offering of Securities
Dec 8, 20258-KCurrent Report
Nov 14, 2025SCHEDULE 13G/AFiling
Nov 14, 2025SCHEDULE 13G/AFiling
Nov 12, 202510-QQuarterly Report
Nov 12, 20258-KCurrent Report
Nov 6, 20258-KCurrent Report
View All SEC Filings